Venture import play
3SBio launches Chinese government-supported VC fund to build out pipeline
3SBio Inc. (NASDAQ:SSRX) is forming 3SBio Ventures, a Chinese government-supported entity that will make strategic investments in small to mid-sized U.S. life science plays. In exchange for equity, 3SBio hopes to obtain Chinese licensing rights to biologics for oncology, nephrology and inflammatory diseases.
One of the most important features of the fund,